U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Vitelliform macular dystrophy 2(BMD; VMD2)

MedGen UID:
411553
Concept ID:
C2745945
Disease or Syndrome
Synonyms: Best disease; Best macular dystrophy; Best Vitelliform Macular Dystrophy; Best vitelliform macular dystrophy, multifocal; Macular degeneration, polymorphic vitelline; VITELLIFORM MACULAR DYSTROPHY, EARLY-ONSET; VITELLIFORM MACULAR DYSTROPHY, JUVENILE-ONSET
SNOMED CT: Best vitelliform macular dystrophy (763387005); Best disease (763387005); Polymorphic vitelline macular degeneration (763387005); Early-onset vitelliform macular dystrophy (763387005); Juvenile-onset vitelliform macular dystrophy (763387005); BMD - Best macular dystrophy (763387005); Vitelliform macular dystrophy type 2 (763387005); BVMD - Best vitelliform macular dystrophy (763387005)
Modes of inheritance:
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
 
Gene (location): BEST1 (11q12.3)
 
Monarch Initiative: MONDO:0007931
OMIM®: 153700
Orphanet: ORPHA1243

Disease characteristics

Excerpted from the GeneReview: Bestrophinopathies
Bestrophinopathies, the spectrum of ophthalmic disorders caused by pathogenic variants in BEST1, are typically characterized by retinal degeneration. The four recognized phenotypes are the three autosomal dominant disorders: Best vitelliform macular dystrophy (BVMD), BEST1 adult-onset vitelliform macular dystrophy (AVMD), and autosomal dominant vitreoretinochoroidopathy (ADVIRC); and autosomal recessive bestrophinopathy (ARB). Onset is usually in the first decade (except AVMD in which onset is age 30 to 50 years). Slow visual deterioration is the usual course. Choroidal neovascularization can occur in rare cases. ADVIRC is also associated with panophthalmic involvement including nanophthalmos, microcornea, hyperopia, and narrow anterior chamber angle with angle closure glaucoma. [from GeneReviews]
Authors:
Ian M MacDonald  |  Thomas Lee  |  Jessica Lawrence   view full author information

Additional description

From OMIM
Best vitelliform macular dystrophy is an early-onset autosomal dominant disorder characterized by large deposits of lipofuscin-like material in the subretinal space, which creates characteristic macular lesions resembling the yolk of an egg ('vitelliform'). Although the diagnosis of Best disease is often made during the childhood years, it is more frequently made much later and into the sixth decade of life. In addition, the typical egg yolk-like lesion is present only during a limited period in the natural evolution of the disease; later, the affected area becomes deeply and irregularly pigmented and a process called 'scrambling the egg' occurs, at which point the lesion may appear as a 'bull's eye.' The disorder is progressive and loss of vision may occur. A defining characteristic of Best disease is a light peak/dark trough ratio of the electrooculogram (EOG) of less than 1.5, without aberrations in the clinical electroretinogram (ERG). Even otherwise asymptomatic carriers of BEST1 mutations, as assessed by pedigree, will exhibit an altered EOG. Histopathologically, the disease has been shown to manifest as a generalized retinal pigment epithelium (RPE) abnormality associated with excessive lipofuscin accumulation, regions of geographic RPE atrophy, and deposition of abnormal fibrillar material beneath the RPE, similar to drusen. Occasional breaks in the Bruch membrane with accompanying neovascularization have also been reported, although Best disease is not noted for extensive choroidal neovascularization. Many of these features are also found in age-related macular degeneration (see 603075) (summary by Braley, 1966; White et al., 2000; Marmorstein et al., 2000; Leroy, 2012). For a discussion of genetic heterogeneity of vitelliform macular dystrophy, see VMD1 (153840).  http://www.omim.org/entry/153700

Clinical features

From HPO
Cystoid macular degeneration
MedGen UID:
472900
Concept ID:
C0154850
Disease or Syndrome
A form of macular degeneration characterized by the presence of multiple cysts in the macula.
Reduced visual acuity
MedGen UID:
65889
Concept ID:
C0234632
Finding
Diminished clarity of vision.
Abnormal electroretinogram
MedGen UID:
96908
Concept ID:
C0476397
Finding
Any abnormality of the electrical responses of various cell types in the retina as measured by electroretinography.
Macular dystrophy
MedGen UID:
196451
Concept ID:
C0730292
Disease or Syndrome
Macular dystrophy is a nonspecific term for premature retinal cell aging and cell death, generally confied to the macula in which no clear extrinsic cause is evident.
Subretinal fluid
MedGen UID:
740519
Concept ID:
C1720732
Finding
Edema/fluid accumulating between the retinal pigment epithelium and Bruch's membrane.
Visual impairment
MedGen UID:
777085
Concept ID:
C3665347
Finding
Visual impairment (or vision impairment) is vision loss (of a person) to such a degree as to qualify as an additional support need through a significant limitation of visual capability resulting from either disease, trauma, or congenital or degenerative conditions that cannot be corrected by conventional means, such as refractive correction, medication, or surgery.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVVitelliform macular dystrophy 2

Professional guidelines

PubMed

Beryozkin A, Sher I, Ehrenberg M, Zur D, Newman H, Gradstein L, Simaan F, Rotenstreich Y, Goldenberg-Cohen N, Bahar I, Blumenfeld A, Rivera A, Rosin B, Deitch-Harel I, Perlman I, Mechoulam H, Chowers I, Leibu R, Ben-Yosef T, Pras E, Banin E, Sharon D, Khateb S
Invest Ophthalmol Vis Sci 2024 Feb 1;65(2):39. doi: 10.1167/iovs.65.2.39. PMID: 38411968Free PMC Article
Bitner H, Schatz P, Mizrahi-Meissonnier L, Sharon D, Rosenberg T
Am J Ophthalmol 2012 Aug;154(2):403-412.e4. Epub 2012 May 24 doi: 10.1016/j.ajo.2012.02.036. PMID: 22633354
Booij JC, Boon CJ, van Schooneveld MJ, ten Brink JB, Bakker A, de Jong PT, Hoyng CB, Bergen AA, Klaver CC
Ophthalmology 2010 Jul;117(7):1415-22. Epub 2010 Apr 9 doi: 10.1016/j.ophtha.2009.11.044. PMID: 20381869

Curated

Ramsden SC, Davidson AE, Leroy BP, Moore AT, Webster AR, Black GC, Manson FD
Eur J Hum Genet 2012 May;20(5) Epub 2012 Jan 11 doi: 10.1038/ejhg.2011.251. PMID: 22234150Free PMC Article

Recent clinical studies

Etiology

Parodi MB, Iacono P, Del Turco C, Bandello F
Am J Ophthalmol 2014 Dec;158(6):1247-1252.e2. Epub 2014 Aug 28 doi: 10.1016/j.ajo.2014.08.028. PMID: 25174897

Diagnosis

Parodi MB, Iacono P, Del Turco C, Bandello F
Am J Ophthalmol 2014 Dec;158(6):1247-1252.e2. Epub 2014 Aug 28 doi: 10.1016/j.ajo.2014.08.028. PMID: 25174897
Boon CJ, Klevering BJ, den Hollander AI, Zonneveld MN, Theelen T, Cremers FP, Hoyng CB
Arch Ophthalmol 2007 Aug;125(8):1100-6. doi: 10.1001/archopht.125.8.1100. PMID: 17698758
Krämer F, Mohr N, Kellner U, Rudolph G, Weber BH
Hum Mutat 2003 Nov;22(5):418. doi: 10.1002/humu.9189. PMID: 14517959

Therapy

Koirala A, Makkia RS, Conley SM, Cooper MJ, Naash MI
Hum Mol Genet 2013 Apr 15;22(8):1632-42. Epub 2013 Jan 18 doi: 10.1093/hmg/ddt013. PMID: 23335596Free PMC Article

Prognosis

Boon CJ, Klevering BJ, den Hollander AI, Zonneveld MN, Theelen T, Cremers FP, Hoyng CB
Arch Ophthalmol 2007 Aug;125(8):1100-6. doi: 10.1001/archopht.125.8.1100. PMID: 17698758
Kachi S, Esumi N, Zack DJ, Campochiaro PA
Gene Ther 2006 May;13(9):798-804. doi: 10.1038/sj.gt.3302700. PMID: 16467860

Clinical prediction guides

Koirala A, Makkia RS, Conley SM, Cooper MJ, Naash MI
Hum Mol Genet 2013 Apr 15;22(8):1632-42. Epub 2013 Jan 18 doi: 10.1093/hmg/ddt013. PMID: 23335596Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • EuroGentest, 2012
      Clinical utility gene card for: BEST1-related dystrophies (Bestrophinopathies).

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...